Cryoport Inc (NASDAQ: CYRX) has reported E.P.S. of $-0.31 for its third fiscal quarter (ending September 30) versus $-0.15 for the same period a year ago. This performance was $-0.02 short of the consensus estimate […]
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has reported E.P.S. of $2.33 for its third fiscal quarter (ending September 30) versus $-0.31 for the same period a year ago. Relative to the consensus estimate of $4.93, this […]
Recent extremely meaningful negative changes in investment behavior have impacted Steris Plc (NYSE: STE): the stock’s recent price decline challenged its longer term uptrend, the stock fell on very heavy volume, and negative upside/downside volume […]
SFL Corp Ltd (NYSE: SFL) has reported E.P.S. of $0.23 for its third fiscal quarter (ending September 30) versus $0.39 for the same period a year ago — a decline of -41%. However, this result […]
For its third fiscal quarter (ending September 30), Southwest Gas Holdings Inc (NYSE: SWX) has reported E.P.S. of $0.05 compared to $-0.18 a year ago. This performance was $0.02 better than the consensus estimate of […]
Natera Inc (NASDAQ: NTRA) has reported E.P.S. of $-0.95 for its third fiscal quarter (ending September 30) versus $-1.25 for the same period a year ago. Relative to the consensus estimate of $-0.97, this was […]
For its third fiscal quarter (ending September 30), Ceva Inc (NASDAQ: CEVA) has reported E.P.S. of $-0.12 compared to $-0.89 a year ago. This performance was $-0.16 short of the consensus estimate of $0.04. E.P.S. […]
Xenon Pharmaceuticals Inc (NASDAQ: XENE) has reported a loss for its third fiscal quarter (ending September 30) of $-0.73 versus a loss $-0.57 for the same period a year ago. This result exceeded the consensus […]
ICL GROUP LTD (NYSE: ICL) has reported E.P.S. of $0.11 for its third fiscal quarter (ending September 30) versus $0.49 for the same period a year ago — a decline of -78%. Relative to the […]
Centrus Energy Corp (NYSEAMERICAN: LEU) stock closed at $48.51 on 11/8/23 after a major decline of -10.9%. The stock has been exceptionally strong relative to the market over the last nine months but has declined […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research